Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Depreciation & Amortization (CF) (2020 - 2023)

Historic Depreciation & Amortization (CF) for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $72000.0.

  • Terns Pharmaceuticals' Depreciation & Amortization (CF) fell 2258.06% to $72000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $292000.0, marking a year-over-year decrease of 3966.94%. This contributed to the annual value of $319000.0 for FY2024, which is 924.66% up from last year.
  • As of Q4 2023, Terns Pharmaceuticals' Depreciation & Amortization (CF) stood at $72000.0, which was down 2258.06% from $72000.0 recorded in Q3 2023.
  • In the past 5 years, Terns Pharmaceuticals' Depreciation & Amortization (CF) registered a high of $172000.0 during Q1 2021, and its lowest value of $72000.0 during Q2 2023.
  • In the last 4 years, Terns Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $103500.0 in 2020 and averaged $105125.0.
  • In the last 5 years, Terns Pharmaceuticals' Depreciation & Amortization (CF) skyrocketed by 9545.45% in 2021 and then plummeted by 4782.61% in 2023.
  • Terns Pharmaceuticals' Depreciation & Amortization (CF) (Quarter) stood at $106000.0 in 2020, then increased by 7.55% to $114000.0 in 2021, then fell by 18.42% to $93000.0 in 2022, then fell by 22.58% to $72000.0 in 2023.
  • Its Depreciation & Amortization (CF) stands at $72000.0 for Q4 2023, versus $72000.0 for Q3 2023 and $72000.0 for Q2 2023.